Abivax S.A. (ABVX) Financials

ABVX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 627.0 million 134.7 million
Dec. 31, 2025 685.7 million 151.5 million
Sept. 30, 2025 765.2 million 165.2 million
June 30, 2025 141.0 million 197.9 million

ABVX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -58.0 million 25.9 million
Dec. 31, 2025 -83.7 million -12.9 million
Sept. 30, 2025 -83.6 million 13.5 million
June 30, 2025 -78.6 million 13.0 million

ABVX Net Income

No data available :(

ABVX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 - - 1.7 million
Dec. 31, 2025 622.4 million 35.5 million 650097
Sept. 30, 2025 - - 1.8 million
June 30, 2025 71.8 million 41.0 million 2.2 million

ABVX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 90.9 million
Dec. 31, 2025 81.6 million
Sept. 30, 2025 91.3 million
June 30, 2025 74.7 million

ABVX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 61881 56.8 million 9.2 million -
Dec. 31, 2025 9391 52.1 million 32.5 million 16435
Sept. 30, 2025 - 65.0 million 32.1 million -
June 30, 2025 74255 45.5 million 10.5 million 40074

ABVX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 -2.4 million 1.2 million
Sept. 30, 2025 - -
June 30, 2025 2.4 million -

ABVX

Price: $99.44

52 week price:
5.69
148.83

Earnings Per Share: -5.36 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 5.9 billion

Links: